ARMISTICE CAPITAL LLC 13D/13G Filings for Aytu BioPharma, Inc. (AYTU)

ARMISTICE CAPITAL LLC 13D and 13G filings for Aytu BioPharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-12-21
5:07 pm
Purchase
2020-12-11 13D Aytu BioPharma, Inc.
AYTU
ARMISTICE CAPITAL LLC 26,666,680
7.700%
25,851,934increase
(+3173.01%)
Filing